TG Therapeutics
TGTX
#3080
Rank
โ‚น440.95 B
Marketcap
โ‚น2,777
Share price
0.23%
Change (1 day)
-0.11%
Change (1 year)

Revenue for TG Therapeutics (TGTX)

Revenue in 2025 (TTM): โ‚น46.07 Billion

According to TG Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚น47.91 Billion. In 2024 the company made a revenue of โ‚น28.22 Billion an increase over the revenue in the year 2023 that were of โ‚น19.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TG Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น46.07 B63.25%
2024 โ‚น28.22 B45.09%
2023 โ‚น19.45 B8343.66%
2022 โ‚น0.23 B-53.73%
2021 โ‚น0.49 B4378.71%
2020 โ‚น11.11 M2.56%
2019 โ‚น10.83 M1.99%
2018 โ‚น10.62 M9.44%
2017 โ‚น9.71 M-6.22%
2016 โ‚น10.35 M2.26%
2015 โ‚น10.12 M4.86%
2014 โ‚น9.65 M2.59%
2013 โ‚น9.41 M802.65%
2012 โ‚น1.04 M
2011 N/A
2010 N/A
2009 N/A
2000 โ‚น0.25 B379.44%
1999 โ‚น52.16 M-61.66%
1998 โ‚น0.13 B1054.06%
1997 โ‚น11.78 M9.32%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Dr. Reddy's Laboratories
RDY
โ‚น356.54 B 644.06%๐Ÿ‡ฎ๐Ÿ‡ณ India
Alkermes
ALKS
โ‚น137.05 B 186.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland